In ovarian cancer MiD49 mRNA and protein expression was increased in tumorigenic tissue in comparison to peritumor samples, and higher MiD49 expression correlated with worse overall and progression-free survival (Zhao et al., 2020) (Table 2). This evidence concerns the gene MIEF2 and ovarian carcinoma.